, Tracking Stock Market Picks
Enter Symbol:
Endo Pharmaceuticals Holdings Inc. (ENDP) [hlAlert]

up 373.90 %

Endo Pharmaceuticals Holdings Inc. (ENDP) rated Overweight with price target $24 by Thomas Weisel

Posted on: Tuesday,  Jun 2, 2009  8:25 AM ET by Thomas Weisel

Thomas Weisel rated Overweight Endo Pharmaceuticals Holdings Inc. (NASDAQ: ENDP) on 06/02/2009, when the stock price was $16.67.
Since then, Endo Pharmaceuticals Holdings Inc. has gained 373.91% as of 12/09/2015's recent price of $79.00.
If you would have followed this Thomas Weisel's recommendation on ENDP, you would have gained 373.9% of your investment in 2381 days.

Endo Pharmaceuticals Holdings Inc., through its wholly owned subsidiaries, Endo Pharmaceuticals Inc. and Endo Inc., is engaged in the research, development, sales and marketing of branded and generic prescription pharmaceuticals used primarily for the treatment and management of pain.

At Thomas Weisel Partners, the role of Research is to contribute to our clients' decision process in ways that lead to better investment decisions. We cover the key growth sectors of the economy including Consumer, Energy, Financial Services, Healthcare, Internet, Media & Telecom, Metals & Mining and Technology.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
6/2/2009 8:25 AM Buy
16.67 24.00
as of 12/31/2009
1 Week up  64.93 %
1 Month up  52.88 %
3 Months up  48.82 %
1 YTD up  102.03 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy